Global Primary Biliary Cholangitis Market Analysis

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Global Primary Biliary Cholangitis Market Analysis

  • Pharmaceutical
  • Jan 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

原発性胆汁性肝硬変は、炎症、線維化、胆管閉塞を引き起こし、肝臓内の細い胆管が失われる慢性肝疾患です。自己免疫、感染症、遺伝的素因などが原因として考えられます。かゆみ、骨粗鬆症、高コレステロール血症、脂肪および脂溶性ビタミンの吸収不良は、原発性胆汁性肝硬変の症状であり、肝腫大、色素沈着、脾腫、黄疸、乾燥症候群、カイザー・フライシャー輪へと進行する可能性があります。原発性胆汁性肝硬変は時間の経過とともに進行し、最終的には肝臓の機能が完全に停止する可能性があります。

Filled Map Analysis

Frequently Asked Questions

The market is segmented based on Segmentation, By Diagnosis (Imaging Tests, Blood Tests, Others), Treatment Type (Liver Transplantation, Drug Therapy, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2032 .
The Global Primary Biliary Cholangitis Market size was valued at USD 1.05 USD Billion in 2024.
The Global Primary Biliary Cholangitis Market is projected to grow at a CAGR of 10.5% during the forecast period of 2025 to 2032.
The major players operating in the market include F. Hoffmann-La Roche Ltd. , Mylan N.V. , Teva Pharmaceutical Industries Ltd. , Sanofi , Pfizer Inc. , GlaxoSmithKline plc , Novartis AG , Merck &amp, Co.Inc. , Allergan , AstraZeneca , Johnson &amp, Johnson Private Limited , Hikma Pharmaceuticals PLC , Bristol-Myers Squibb Company , Bayer AG , Boehringer Ingelheim International GmbH. , Dr. Reddy&rsquo,s Laboratories Ltd. , Gilead SciencesInc. , Amgen Inc. , Eli Lilly and Company , AbbVie Inc. , Lupin , Allergan .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.